Recently, significant advances in the DNA analysis of VH andor VL genes of B-cell neoplasms have been made. VH replacement resulting from the recombination of an upstream VH gene to a previously rearranged VHDJH joining has been frequently shown in pediatric B-lineage acute lymphoblastic leukemia (B-ALL)?"' reflecting the presence of intracellular recombinase activity in B-ALL. Intraclonal diversity as a result of ongoing somatic hypermutations in the CDRs of V-region genes also has been described in follicular lymphoma.'2 However, few or no detectable somatic hypermutations in the V-region genes have been reported in B-ALL?." Burkitt's lymphoma,13 B-lineage chronic lymphocytic leukemia (B-CLL),'"16 or small lymphocytic lymphoma." Therefore, these neoplastic cells are thought to arise from more immature cells than follicular lymphoma cells. We and other groups have found frequent somatic mutations in the IgH gene with no intraclonal variation in multiple myeloma (MM),I8,l9 indicating that MM is a neoplasm of B-lineage cell which has already undergone antigen-dependent selection.
per base pair cell division) in the complementaritydetermining regions (CDRs) of the rearranged IgH gene during the generation of memory B cells in germinal cent e r~.~" The number of mutations generated during the process of somatic mutation has been shown to increase during the secondary and tertiary antibody responses to antigen.8 Thus, the DNA analysis of V(D)J recombination and somatic mutations in CDRs delineates the normal counterparts of B-cell neoplasms and the relation between antigenic stimulation and carcinogenesis in B-cell neoplasms.
Recently, significant advances in the DNA analysis of VH andor VL genes of B-cell neoplasms have been made. VH replacement resulting from the recombination of an upstream VH gene to a previously rearranged VHDJH joining has been frequently shown in pediatric B-lineage acute lymphoblastic leukemia (B-ALL)?"' reflecting the presence of intracellular recombinase activity in B-ALL. Intraclonal diversity as a result of ongoing somatic hypermutations in the CDRs of V-region genes also has been described in follicular lymphoma.'2 However, few or no detectable somatic hypermutations in the V-region genes have been reported in B-ALL?." Burkitt's lymphoma,13 B-lineage chronic lymphocytic leukemia (B-CLL),'"16 or small lymphocytic lymphoma." Therefore, these neoplastic cells are thought to arise from more immature cells than follicular lymphoma cells. We and other groups have found frequent somatic mutations in the IgH gene with no intraclonal variation in multiple myeloma (MM),I8,l9 indicating that MM is a neoplasm of B-lineage cell which has already undergone antigen-dependent selection.
Waldenstrom's macroglobulinemia (W) is a malignant lymphoplasmoproliferative disorder with monoclonal pentameric IgM production. Analysis of phenotypic markers 
MATERIALS AND METHODS
Patients. Seven patients with WM ( W " 1 through WM-7) and ten patients with CLL (CLL-1 through CLL-10) were studied ( Table   I ). The diagnosis of W M was made according to the criteria of MacKenzie and Fudenberg." Six patients were newly diagnosed, and one was at relapse after chemotherapy. The tonsillectomy specimen of WM-4 showed a follicular medium-sized cell type of NHL. The lymph node biopsy specimen of W " 6 showed a diffuse mixed cell type of NHL.
All of the CLL patients were newly diagnosed according to the * Nineteen months after first presentation, when the patient suffered from a bone lymphoma. § Abdominal subcutaneous tumor developed 6 months after initial presentation.
criteria of the French-American-British Cooperative group.z6 The tumor cells from all the C U patients, except for those from CLL-8, expressed the CD5 antigen. That patient was diagnosed with an isotype-switched (IgG) CLL variant. Another CLL patient (CLL-7) had an increased number of mature lymphocytes with prolymphocytes in the peripheral blood (PB) and bone marrow (BM) and was diagnosed CLLPL. Monoclonal gammanopathy and Bence-Jones proteinuria were absent in all of the CLL patients. Two patients progressed to high grade NHL during our study; CLL-3 suffered from bone lymphoma at his right femur 19 months after his first presentation. A needle-biopsy specimen showed accumulation of large lymphocytes in the osteolytic lesion. The PB tumor cells of CLL-3 initially expressed CD5 but not after the Richter's transformation. CLL-4 presented with swelling of paraaortic lymph nodes and a subcutaneous abdominal tumor 6 months &er his initial presentation. A diagnostic biopsy specimen of the subcutaneous tumor indicated a large cell lymphoma. The tumor cells of these CLL cases with RS and of CLL-8 and CLL-9 had relatively abundant cytoplasm compared with other common CLL cells.
This investigation was approved by the Institutional Review Board of the University of Tokushima (Tokushima, Japan), and all materials were taken after obtaining informed consent from the patients.
Cell isolation. PB of W " 2 , W " 3 , and all the CLL patients; BM aspirates of WM-1, W -5 , and WM-7; a tonsil of w " 4 ; and a cervical lymph node of WM-6 were obtained at diagnosis as sources of DNA. A BM aspirate of W " 5 was obtained at relapse after chemotherapy. Paired samples were obtained in some patients; the materials before and after the Richter's transformation were available in CLL-3 and CLL-4. PB at diagnosis and advanced phase was obtained from WM-2 ( Table 1) . The mononuclear cells (MNCs) were prepared by centrifugation over Ficoll-Conray (specific gravity, 1.077). We confirmed that each specimen contained from 30% to 95% tumor cells by morphology and immunophenotyping. High molecular weight DNAs were extracted from MNCs by the method described by Sambrook et al.*' PCR procedure. DNA primers were synthesized by a DNA synthesizer and purified by HPLC. The primers used were VPst: Perkin Elmer-Cetus, Norwalk, CT) and mineral oil to prevent evaporation. PCR was performed with 35 cycles of a denaturing step at 94°C for 1 minute, an annealing step at 55°C for l minute, and an elongation step at 72°C for 1 minute. The final cycle was completed with a 4-minute elongation step. We used VEco as the sense primer for the initial PCR amplification. However, the VPst primer was used for samples that failed to amplify the rearranged IgH genes with the VEco primer.
DNA sequencing. The amplified DNAs were separated by elec- and the small-sized band from CLL-4 were out of the reading frame; therefore, these sequences were considered to be derived from the nonfunctional alleles (out-of-frame sequences not shown).
5'-GTCCTGCAGGC(C/T)(CIT)CCGG(AIG)AA(AlG)(A/G)GT-
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Somatic mutations. Replacement mutations (MS) that
resulted in amino acid substitutions were detected in the D and/or JH segments of all of the 7 WM patients. There were RMs in the JH segment of 6 of 7 WM patients (85.7%) and in the D segment of 3. In contrast, RMs were not found in 6 of the 10 CLL patients. We found three RMs in the D and JH segments of CLL-3 and an RM in the D segment of CLL-4. Both of these 2 CLL patients had progressed to NHL, as described in the Materials and Methods. RMs were also detected in the D segment of CLL-8 and in the JH segment of CLL-9. Both of the nucleotide insertions and adjoining substitutions in the J H~ segment of CLL-4 and the DXP'1 segment of CLL-7 were probably generated during the process of VHDJH recombination rather than during a process of somatic hypermutation. The DNA sequences of the rearranged IgH genes isolated from the paired specimens from WM-2, CLL-3, and CLL-4 were completely identical with no additional mutations. Single point mutations from the prototypic sequence were rarely detected. The frequency of these mutations was less than 1 in 1,200 bases in this study and was almost the same as the expected incidence of misincorporations of Tuq polymerase (data not shown). Thus, we concluded that ongoing somatic mutations were absent in all the cases of WM and CLL. Additionally, there was no evidence of VH replacements in WM or CLL, indicating that the V(D)J recombinase system had been already inactivated in both the WM and CLL cells.
We focused on mutations in the JH segment, because the germline sequences and polymorphisms of JH genes are wellknown compared with those of the VH and D genes. Somatic mutations in each JH gene are summarized in Fig 2, including our previous data of 11 cases of ".l9
Five of the twelve amino acid substitutions (41.7%) that resulted from somatic mutations in the JH segments of WM and CLL cells were found at codon 102. TATTGTACT 66A6  CCACC  TGCTCAAE  TTACTACTACTACTAC66TITGBICGTCT6666CCAA666ACCAC  N  (DLR1) (JMW mutations such as V~3 2 and V H~ lpl, resulting in the synthesis of polyreactive autoantibodies with low affinit~.'~.~' We also found no mutations in D and JH segments of common CLL. A nucleotide insertion and adjoining substitution were observed in a patient with CLLPL, but these were thought to be generated in the process of VHDJH recombination. Therefore, most CLLs and CLL/PLs may arise from CD5+ B cells, a distinct subpopulation that, in mice, originates early in ontogeny and is 10ng-lived,2~,~~ although CD5 is also known in humans to mark an activation or differentiation state of B cells." Of interest is that 2 of our CLL patients with RMs in the D and/or JH segments had progressed to the high-grade lymphomas of RS. Cherepakhin et a14' also have described a similar case of high-grade CD5"B-cell lymphoma comprised of a clonal expansion of mutant cells derived from the preceding CDY-CLL cells. RM in the D segment was also found in 1 patient with IgG variant CLL. We found an RM in the JH segment of another CLL case whose tumor cells had relatively abundant cytoplasm. The monoclonal CD5' small lymphocytes observed in WM and CLL with RS cases must be distinct from their counterparts in common CLL with unmutated genes. Thus, CLL with RS, isotype-switched IgG or IgA CLL variant^,^.^^ and CD5" CLL with ongoing somatic mutation in the VH gene48 show characteristics of different B-cell subpopulations or different stages of B-cell differentiation. These several lines of evidence indicate that CLL may be a heterogeneous group of clonal B-cell disorders, encompassing common forms that express restricted and nonmutated V-region genes to less common variants manifesting more differentiated and somatically mutated ones.
We also found that codons 102 and 105 of the JH segment were hot spots for mutation (Fig 2) . There were 23 amino acid substitutions in the JH segments of tumor cells from our 7 WM, 10 CLL, and l 1 MM cases. There were nine amino acid substitutions at codon 102 (9 the J H~ segment but were not found at codon 102 of the J H~, J H~, or J H~ segments, indicating that this codon may play a critical role in the formation of affinity-maturated antibodies. In addition, the pattern of JH-utilization frequency in W, CLL, and MM cells was as identical to that in normal adult PB B lymphocytes ( J H~, 52.5%; J H~, 22.2%; and J H~, 15.2%).35 Thus, the preferential use of J H~ reflects the normal repertoire rather than disease-specific over-representation. We also found prevalent use of DXP family genes in CLL (50%), although the significance remains to be elicited.
The DNA analysis of the CDR3 is useful in studying the cellular history of B-cell neoplasms and in distinguishing unique subsets from heterogeneous B-cell neoplasia.
